Terlipressin
Assess TERLIpressin for Hepatorenal Syndrome
As a clinical pharmacist, you should evaluate the use of terlipressin for hepatorenal syndrome. Terlipressin ( Glypressin, Haemoxamine ) will be the first FDA-approved medication for hepatorenal syndrome with acute kidney injury (HRS-AKI). HRS-AKI typically occurs in patients with cirrhosis and ascites who develop splanchnic vasodilation. This causes decreased perf…
قراءة المزيد
Meds in Liver Disease
Using of albumin for decompensated liver disease
As a hospital pharmacist, you’ll be asked about the role of IV albumin in patients hospitalized with acute decompensated liver disease . New evidence shows that giving these patients DAILY albumin to raise and maintain levels above 3 g/dL does NOT reduce infection, kidney dysfunction, or death. Plus albumin may increase pulmonary edema risk, and It is also expensiv…
قراءة المزيد
Meds in Liver Disease
Myths about drugs in chronic LIVER disease
As a pharmacist, you will hear myths perpetuated about medications in chronic liver disease. This means that patients with viral hepatitis, fatty liver disease , or cirrhosis can miss out on appropriate therapy. Get our note, " Prescribing medications in patients with liver cirrhosis "... Myth 1. Medications often impair liv…
قراءة المزيد
Terlipressin
Pharmacotherapy of cirrhosis
Overview ㅡ Cirrhosis is defined as diffuse injury to liver characterized by destruction of hepatocytes and their replacement by fibrous tissue. Typically, the disease develops slowly over months or years. Early on, there are often no symptoms. As the disease worsens, a person may become tired, weak, itchy, have swelling in the lower legs, develop yellow skin (elevat…
قراءة المزيد
Social Plugin